• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Precious Metals Market
    Precious Metals News
    Precious Metals Stocks
    • Precious Metals Market
    • Precious Metals News
    • Precious Metals Stocks

    North American Palladium Releases Q3 Results

    Teresa Matich
    Nov. 05, 2014 10:53AM PST
    Precious Metals Investing

    North American Palladium (TSX:PDL) has released its development, operating and financial results for the third quarter ended September 30 2014. The company reported a net loss of $18.8 million for the quarter compared to a net loss of $5.3 million for the same quarter in 2013.

    North American Palladium (TSX:PDL) has released its development, operating and financial results for the third quarter ended September 30 2014. The company reported a net loss of $18.8 million for the quarter compared to a net loss of $5.3 million for the same quarter in 2013.

    As quoted in the press release, highlights of results included:

    • Sold 36,430 ounces of payable palladium at a cash cost per ounce(1) of US$589. Year to date cash cost per ounce is US$527.
    • Revenue of $46.4 million was an increase of $13.1 million or 39% compared to the same period in 2013 due to more favorable exchange rates, higher palladium ounces sold and higher palladium prices.
    • Adjusted EBITDA(1) of $8.3 million for the quarter and $28.5 million year to date.
    • Realized palladium selling price of US$860 per ounce, giving a palladium operating margin of US$271 per ounce, or US$9.9 million. Palladium prices remain strong, with the November 4, 2014 price at US$786 per ounce.

    North American Palladium CEO, Phil du Toit, said:

    Taking a view on the progress from 2013 to where we are today, we are pleased with what has been achieved during construction in 2013, commissioning and production build up in 2014 and the related financings. Although the third quarter presented challenges on grade due to mining sequence, equipment availability and the unfortunate incident of a mine fatality, the fourth quarter is off to a good start and we remain on track to meet our longer-term objectives. The exploration results so far in 2014 are very encouraging. We will keep the market apprised of progress.

    Click here to read the North American Palladium (TSX:PDL) press release

    See this press release on Marketwire

    north-american-palladiumfinancial-resultstsx-pdl
    The Conversation (0)

    Go Deeper

    AI Powered
    Hand holding two 1 ounce palladium bars in plastic cases.

    Palladium Price Forecast: Top Trends for Palladium in 2026

    Palladium Closing Price Gap on Platinum

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES